The important activity for fund was in 2019. Considering the real fund results, this Corporate Investor is 47 percentage points more often commits exit comparing to other organizations. The common things for fund are deals in the range of 100 thousands - 1 million dollars. The fund is constantly included in less than 2 investment rounds annually.
The usual cause for the fund is to invest in rounds with 1-2 partakers. Despite the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), startups are often financed by Bios Partners, Washington Research Foundation., National Cancer Institute SBIR Development Center. The meaningful sponsors for the fund in investment in the same round are National Institutes of Health. In the next rounds fund is usually obtained by U.S. Department of Defense, National Science Foundation, KdT Ventures.
Among the most successful fund investment fields, there are Health Care, Alternative Medicine. Among the most popular portfolio startups of the fund, we may highlight Azitra. Besides, a startup needs to be aged 4-5 years to get the investment from the fund.
Related Funds
Fund Name | Location |
Acon Ventures | California, San Francisco, United States |
Analyst | - |
Asahi Kasei Medical Europe | Frankfurt, Germany, Hessen |
Aviva Canada | Canada, Ontario, Toronto |
Blockbuster | Colorado, Denver, United States |
Carphone Warehouse | England, London, United Kingdom |
Company X Media | New York, New York, United States |
Deutsche Bank Securities | New York, New York, United States |
Digital Assets Deployment | Community of Madrid, Madrid, Spain |
ELEME | China, Putuo, Shanghai |
European Research Council | Belgium, Brussels, Brussels Hoofdstedelijk Gewest |
Juren Capital | China, Hangzhou, Zhejiang |
Karsan Otomotiv | - |
Mack Real Estate Group | - |
Omnicom Group | New York, New York, United States |
The Walden Group | New York, Tarrytown, United States |
The9 | China, Shanghai |
Xilinx | California, San Jose, United States |
Zijing Capital | - |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.